Skip to main content
Novo Nordisk A/S (ETR:NOV)
Germany flag Germany · Delayed Price · Currency is EUR
84.40
+4.72 (5.92%)
Feb 21, 2025, 5:39 PM CET

Novo Nordisk Revenue

In the year 2024, Novo Nordisk had annual revenue of 290.40B DKK with 25.03% growth. Novo Nordisk had revenue of 85.68B in the quarter ending December 31, 2024, with 30.09% growth.

Revenue
290.40B DKK
Revenue Growth
+25.03%
P/S Ratio
n/a
Revenue / Employee
3.75M DKK
Employees
77,349
Market Cap
374.90B EUR

Revenue Chart

* This company reports financials in DKK.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024290.40B58.14B25.03%
Dec 31, 2023232.26B55.31B31.26%
Dec 31, 2022176.95B36.15B25.68%
Dec 31, 2021140.80B13.85B10.91%
Dec 31, 2020126.95B4.93B4.04%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Siemens Healthineers AG 22.67B
Merck KGaA 20.96B
Bayer Aktiengesellschaft 46.74B
Fresenius SE & Co. KGaA 22.81B
Sartorius Aktiengesellschaft 3.38B
Fresenius Medical Care AG 19.24B
Carl Zeiss Meditec AG 2.08B
SCHOTT Pharma AG & Co. KGaA 954.68M
Revenue Rankings

Novo Nordisk News

More News